Surgery Plus Photodynamic Therapy for a Diabetic Patient with Cutaneous Infectious Granuloma Caused by Curvularia Lunata.

Xiaoqing Wang,Yuying Qu,Zhiya Yang,Ting Zhang,Yahui Feng,Dongmei Li,Hongxia Yan,Dongmei Shi

DOI: https://doi.org/10.1016/j.pdpdt.2022.103253

IF: 3.577

2023-01-01

Photodiagnosis and Photodynamic Therapy

Abstract:Curvularia lunata (C. lunata) can be easily found in environment and plants and rarely causes human infections. Antifungal agents have been the primary approach to treat such infections; however, adverse hepatotoxic reactions may require discontinuation of the long-term use of antifungal agents in patients with pre-existing liver diseases. New therapeutic approaches are thus needed to cope with these circumstances. Here, we report a 66-year-old diabetic female patient, suffering from a rapidly growing lesion on the nose for 2 months. The patient was diagnosed with cutaneous fungal infection caused by C. lunata, which was based on mycological study and ITS sequencing. The lesion was completely disappeared after a combination of surgery and 3 times of photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) at 9- day intervals. The patient did not receive any antifungal agents during the treatment. There was no recurrence at 6-month fellow-up. In the following in vitro study, C. Lunata growth was significantly inhibited by ALA-PDT treatment. Therapeutic success in this patent suggests that the ALA-PDT method could be a promising treatment for cutaneous fungal infection caused by C. Lunata and others.